erythropoietin mediated neuroprotection through nf-kb
| PAG Title | erythropoietin mediated neuroprotection through nf-kb |
| PAG ID | WAG001039 |
| Type | P |
| Source Link |  BioCarta |
| Publication Reference | NA |
| PAG Description | Erythropoietin (Epo) is most commonly known as the cytokine secreted by the kidneys that stimulates red blood cell production and is used as a drug for the treatment of anemias. Epo is also secreted in the brain in response to hypoxia, such as ischemic stroke. Epo production in the brain is stimulated by the hypoxia-inducible transcription factor HIF-1 (see HIF pathway). Administration of Epo to the brain in rodents before hypoxic stress or other neurol stresses is neuroprotective, preventing neurol apoptosis. The erythropoietin receptor (EpoR) is known to associate with JAK kises that phosphorylate and activate the STAT family of transcription factors (See Epo pathway). The neuroprotection by Epo involves cross-talk between Epo receptor and anti-apoptotic pathways through activation of NF-kB by the JAK2 kise (see NF-kB pathway). Epo stimulates JAK2 phosphorylation of I-kB, releasing NF-kB to translocate into the nucleus and activate transcription of neuroprotective genes. Neuroprotective genes activated by NF-kB include the anti-oxidant enzyme manganese superoxide dismutase and calbindin-D(28k). The erythropoietin receptor is also essential for proper brain development in mice. The absence of EpoR causes high levels of neurol apoptosis in the developing mouse brain, further confirming the important role of Epo as a neuroprotective agent. |
| Species | Homo sapiens |
| Quality Metric Scores | nCoCo Score: 1,577 |
| Information Content | Rich |
| Other IDs | |
| Base PAG ID | WAG001039 |
| Human Phenotyte Annotation | |
| Curator | PAGER curation team |
| Curator Contact | PAGER-contact@googlegroups.com |
">
Something else? Please send us an email!